Table 1.
Participants’ characteristics
| MEAN±SEM | RANGE | |
|---|---|---|
| Male/female | 61(42 obese)/16(8 obese) | |
| Age (years) | 52 ± 2 | 21–69 |
| Weight (kg) | 94.8 ± 1.4 | 69.4–122.0 |
| Height (m) | 1.75 ± 0.01 | 1.52–1.92 |
| BMI (kg/m2) | 30.9 ± 0.3 | 25.6–38.6 |
| Waist (cm) | 104 ± 1 | 77–126 |
| Hip (cm) | 106 ± 1 | 89–125 |
| WHR | 0.98 ± 0.01 | 0.70–1.22 |
| Fasting glucose (mM) | 5.7 ± 0.1 | 4.5–7.5 |
| Fasting insulin (mU/L) | 13.9 ± 0.7 | 2.8–29.3 |
| 2 h glucose (mM) | 6.7 ± 0.2 | 3.4–11.2 |
| HOMA-IR | 3.6 ± 0.2 | 0.7–8.8 |
| HbA1 C (%) | 5.4 ± 0.1 | 4.7–6.7 |
| Fasting FFA (μM) | 615 ± 16 | 399–960 |
| FFA suppression (%) | 52.1 ± 2.3 | 6.1–90.1 |
| EGP suppression (%) | 48.5 ± 2.2 | 5.2–87.2 |
| Rd (μmol/kg/min) | 26.3 ± 1.2 | 9.8–54.0 |
Data are mean ± SD [Range: min-max]; BMI: body mass index, WHR: waist-hip ratio, HOMA-IR: homoeostatic model assessment for insulin resistance, HbA1 C: haemoglobin A1 C, FFA: free fatty acids, EGP: endogenous glucose production, Rd: rate of disappearance.